PolyPid Ltd.NASDAQ: PYPD

Investor Presentation (3e767d)

· Issued by PolyPid Ltd.

On 6ix: 6ix.com/news/polypid-investor-presentation-3e767d

Watch PolyPid's latest callPolypid (NASDAQ:PYPD) Q2 2026 Earnings Call · Replay · Aug 12Read the transcript of Polypid (NASDAQ:PYPD) Q2 2026 Earnings Call
PolyPid's next earnings callPolypid (NASDAQ:PYPD) Q3 2026 Earnings Call · Nov 11, 2026 at 8:30 AM ESTRegister


NASDAQ: PYPD Corporate Presentation

August 2025



PolyPid Overview

Polymer-Lipid Encapsulation matriX (PLEX) Platform

granted and pending patents(1)

Pre-NDA

Lead Product D-PLEX in

stage biopharma company

Unique LOCAL Prolonged Delivery of APIs

Phase 3 trial

OncoPLEX Next Big Opportunity for Solid Tumors

100

employees(1)

Global: Petach Tikva, Israel

US: New Jersey

NASDAQ: PYPD

3

1 As of August '25







Robust Pipeline with Multiple Near- and Longer-Term Inflection Points
Attention: This is an excerpt of the original content. To continue reading it, access the original document here.

PolyPid Ltd. on 6ix

Story so far

Earlier from PolyPid

Later from PolyPid

All PolyPid news releases